IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1200 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1A Rare Case of Life-Threatening Extensive Mucocutaneous Adverse Reaction Induced by Docetaxel in a Breast Cancer Patient: Toxic Epidermal Necrolysis, a Case Report with Review of Literature
Shiv Prasad Shrivastava,Aditya Elhence,Prutha Jinwala,Shashank Bansal,Prakash Chitalkar,Shweta Bhatnagar,Rajesh Patidar,Vikas Asati
Indian Journal of Medical and Paediatric Oncology.2022;43(03)318
[DOI]
2A Rare Case of Life-Threatening Extensive Mucocutaneous Adverse Reaction Induced by Docetaxel in a Breast Cancer Patient: Toxic Epidermal Necrolysis, a Case Report with Review of Literature
Avinash Gupta,Mark Middleton
Indian Journal of Medical and Paediatric Oncology.2011;33(03)935
[DOI]
3Dermatologic adverse effects of breast cancer chemotherapy: a longitudinal prospective observational study with a review of literature
Narges Alizadeh,Seyyed Hossein Mirpour,Abbas Darjani,Rana Rafiei,Elahe Rafiei,Maryam Mohammadhoseini
International Journal of Dermatology.2020;59(7)822
[DOI]
4Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
Hazem Ghebeh,Adher Al-Sayed,Riham Eiada,Leilani Cabangon,Dahish Ajarim,Kausar Suleman,Asma Tulbah,Taher Al-Tweigeri
Scientific Reports.2021;11(1)822
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow